Skip to main content

Immunology of the Eye

Buy Article:

$39.50 plus tax (Refund Policy)

Abstract:

The eye is one of the major targets of allergic disorders, accounting for over 20% of the conditions presenting to the allergist. It is also a major target organ of many systemic immunologic reactions (e.g., cytotoxic antibody mediated-cicatricial pemphigoid, immune complex or cell mediated-vasculitis, uveitis). The allergist/immunologist is uniquely trained to assist the ophthalmologist in the systemic immunologic evaluation and treatment of suspected hypersensitivity allergic and immunologic disorders.

Document Type: Research Article

DOI: https://doi.org/10.2500/108854191779114275

Publication date: 1991-11-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more